This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Faron Pharmaceuticals Oy. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jami Mandelin - Innovator in Antibody Formulations
Introduction: Jami Mandelin is a prominent inventor based in Helsinki, Finland. She is currently associated with Faron Pharmaceuticals Oy, where she contributes to the development of innovative therapeutic solutions. Despite having no granted patents, her work in the field of antibody formulations is noteworthy.
Latest Patent Applications: Jami Mandelin has filed several significant patent applications. One of her latest applications is titled "Stable Anti-CLEVER-1 Antibody Formulation." This invention relates to stable formulations comprising an anti-CLEVER-1 antibody or antigen binding fragment(s), a buffer, and a stabilizing agent. The invention aims to provide stable formulations of an anti-CLEVER-1 antibody for use in treating various diseases and disorders. Another application is "Treatment of Diseases with CLEVER-1 Inhibition in Combination with an Interleukin Inhibitor." This application discusses the use of an agent capable of inhibiting CLEVER-1 expression or binding to CLEVER-1 in combination with an interleukin inhibitor, potentially enhancing treatment efficacy for various diseases.
Conclusion: Jami Mandelin's contributions to the field of antibody formulations reflect her dedication to advancing medical science. Her innovative approaches may lead to significant breakthroughs in the treatment of diseases.